Genesis Therapeutics
CA - BurlingameBiotechnology
Focus: Genesis Therapeutics is an AI-driven drug discovery biotech focused on oncology, neurology, cardiovascular, women's health, and immunology indications. The company operates at Series B stage from Burlingame, CA with a technology-first approach to target identification and validation.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Funding Stage
SERIES B
Total Funding
$200M
Open Jobs
0
About Genesis Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Genesis Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Retinal and Cognitive Dysfunction in Type 2 Diabetes
Retinal FunctionRehabilitation Therapy, Experimental on the BrightArm Compact device
StrokeClinical Trials (1)
Help build intelligence for Genesis Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.